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Single-chain variable fragment (scFv) is a class of engineered antibodies generated by
the fusion of the heavy (VH) and light chains (VL) of immunoglobulins through a short
polypeptide linker. ScFv play a critical role in therapy and diagnosis of human diseases,
and may in fact also be developed into a potential diagnostic and/or therapeutic agent.
However, the fact that current scFv antibodies have poor stability, low solubility, and
affinity, seriously limits their diagnostic and clinical implication. Here we have developed
four different expression vectors, and evaluated their abilities to express a soluble scFv
protein. The solubility and binding activity of the purified proteins were determined using
both SDS-PAGE and ELISA. Amongst the four purified proteins, the Skp co-expressed
scFv showed the highest solubility, and the binding activity to antigen TLH was 3-4 fold
higher than the other three purified scFv. In fact, this scFv is specific for TLH and does not
cross-react with other TLH-associated proteins and could be used to detect TLH directly in
real samples. These results suggest that the pACYC-Duet-skp co-expression vector might
be a useful tool for the production of soluble and functional scFv antibody.
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INTRODUCTION
Single-chain variable fragment (scFv) is a fusion protein formed
by engineering the association of the VH and VL domains of
the antibodies with a short polypeptide linker. scFv specific to
any particular antigen may be easily generated by Phage display
(Wang et al., 2006), and this scFv have been developed to select
molecular targets in cancer research such as in lymphatic invasion
vessels, colon cancer and hepatocarcinoma (Rinderknecht et al.,
2010; Sakai et al., 2010; Sommaruga et al., 2011). Furthermore,
scFv has been extensively used to generate ligands for detecting
pathogenic germs in vitro or in vivo (Wang et al., 2007, 2008a,b;
Zhang et al., 2010; Cattepoel et al., 2011). In comparison to poly-
clonal antibodies or the hybridoma technology, scFv antibody
may be easily manipulated for improving specificity and affinity,
thereby reducing the production cost (Coia et al., 2001; Krag et al.,
2006). Combing scFv with selection panning strategies, we were
able to character the binding properties of scFv and investigate
the potential use of these scFv as diagnostic tools or therapeutic
agents (Eisenhardt et al., 2007; Rothe et al., 2007). However, these
above mentioned applications of scFv were limited by drawbacks
such the formation of inclusion bodies, which often lead to low
binding activity, unstable structure and are cytotoxic to host cells.
Currently, the soluble expression of scFv antibody remains an
awkward plight, so the majority of the work in this field focuses
Abbreviations: V.p, Vibrio parahaemolyticus; TLH, Thermolabile Hemolysin;
IPTG, Isopropyl β-D-1-thiogalactopyranoside; scFv, single chain variable fragment.
on developing a strategy based on molecular manipulation to
improve the stability and solubility of scFv antibody. Till today,
a number of methods have been used to express the scFv anti-
body, including expression of affinity tag fusion (Esposito and
Chatterjee, 2006), co-expression of molecular chaperones, and
folding modulators (De Marco and De Marco, 2004; Sonoda
et al., 2011), extracellular accumulation in a defined medium (Fu,
2010), refolding scFv using detergent and additive (Kudou et al.,
2011) and expression in different host systems (Goulding and
Perry, 2003). Amongst of these methods, expression of affinity
tags fusion protein is the common method to improve the sol-
ubility of target proteins. Previously, some affinity tags such as
thioredoxin (TRX) (Nygren et al., 1994), maltose binding protein
(MBP) (Nallamsetty and Waugh, 2006), N-utilization substance
A (NusA) (Fox and Waugh, 2003), bacteriophage T7 protein
kinase gene (T7PK) (Jurado et al., 2006), small peptide tags
(SET) (Davis et al., 1999), monomeric mutant of the Ocr pro-
tein of bacteriophage T7 (Mocr) and glutathione S-transferase
(GST) were used to enhance the solubility of some of the part-
ner proteins to which they were attached (DelProposto et al.,
2009). Unfortunately, the tags needed to be cleaved as the large
tags usually interfered with the folding of their partner pro-
tein and made them more difficult to assay for activity and for
functional research (Esposito and Chatterjee, 2006). Besides, the
partner proteins often remained insoluble when the fusion tags
were removed, and the entire process of tags removal is costly
and laborious (Esposito and Chatterjee, 2006). Though the use of
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detergents and additives to refold the target protein can assist in
making protein soluble, there is still no guarantee that thesemeth-
ods will be suitable for every protein of interest. When it comes
to expression system, though a number of them, such as E. coli,
Yeast, mammalian, insect cell, wheat germ cell-free expression
system, and plant-based expression system (Goulding and Perry,
2003; Greene, 2004; Daly and Hearn, 2005; Guild et al., 2011), are
available for protein production, the E. coli host system is widely
regarded as the most suitable host for the expression of recom-
binant antibody fragments (Wang et al., 2008a,b). Compared to
other host systems, the E. coli system is an economical, shows
faster growth and is easier to manipulate genetically (Sushma
et al., 2011).
It was also reported that the solubility and affinity of scFv
was improved by co-expression of molecular chaperones such
as Skp, Dsbc, and FkpA (Ow et al., 2010; Sonoda et al., 2011).
In some cases, co-expression of molecular chaperone not only
improves the soluble expression but also increases the cell via-
bility (Ow et al., 2010). Skp is a key periplasmic chaperone
(18 kDa) that plays an important role in folding and assembling
of outer membrane proteins in E. coli, and reports have shown
that the co-expression of Skp facilitates correct folding of the
expressed protein and enhances the solubility and affinity of pro-
teins (Hayhurst and Harris, 1999; Hayhurst et al., 2003; Sonoda
et al., 2011).
In this study, we investigate the effects of the molec-
ular chaperone Skp on the level of expression, solubil-
ity and antigen-binding activity of scFv. The co-expression
vector pACYC-Duet containing two multiple cloning sites
(MCS), was used for the construction and expression of
two target genes in an appropriate host strain. By co-
expression of a periplasmic chaperone (Skp) with scFv, a rel-
atively high amount of soluble scFv antibody was successfully
obtained.
MATERIALS AND METHODS
MATERIALS
V. parahaemolyticusCGMCC1.2164, V. parahaemolyti-
cusCGMCC1.1614, V. parahaemolyticusCGMCC1.1615,
V. parahaemolyticusCGMCC1.1616 were purchased from the
Institute of Microbiology, Chinese Academy of Sciences (Beijing,
China). All other strains were from Fujian Agriculture and
Forestry University (Fujian, China). The plasmids pET28a(+)
and pET32a(+) were purchased from Novagen (Madison, WI,
USA), and the vector pACYC-Duet-1 was generously pro-
vided by Professor Lijun Bi (Institute of Biophysics, Chinese
Academy of Sciences, Beijing China). The vector pGEPi was
generously provided by Dr Mengfei Ho (University of Illinois
at Urbana-Champaign, USA). DNA restriction enzymes were
purchased from Promega (USA). Taq DNA polymerase and
T4 DNA ligase were purchased from Takara (Dalian, China).
Anti 6×His tag monoclonal antibody was purchased from
Abgent (USA), and horseradish peroxidase (HRP)-labeled
goat anti-mouse IgG was from Boster Biological Technology
Co. (Wuhan, China). All oligonucleotides were listed in
Table 1, and all other reagents used were of analytical reagent
grade.
Table 1 | Primers used in the present study.
Primers DNA sequence
Skp-F GGCGAGATCTGACGAAAAAGTGGTTATTAGCTG
Skp-R CGGCTCGAGTTATTTAACCTGTTTCAGTACGTC
scFv-1-F AAGAATTCATGGCCCAGGTCAAACTGCAGGAG
scFv-1-R CCCGCAAGCTTCCGTTTTATTTCCAGCT
scFv-2-F AAGAATTCAGCCCAGGTCAAACTGCAGGAG
scFv-2-R CCCGCAAGCTTCCGTTTTATTTCCAGCT
TLH-F AAACTGGTACCGGTAGAAATGATGAAAAAAACAATCAC
ACTATTAACTGCATTAC
TLH-R GAACCTGCGGCCGCACCAGAACCGAAACGGTACTCGG
CTAAGTTGTTGCTAC
EXPRESSION AND PURIFICATION OF TLH ANTIGEN
The V. parahaemolyticus(CGMCC1.2164) genome was used as a
template to amplify the tlh gene[GeneBank:GU971665.1] (Wang
et al., 2011). Primers with Kpn I and Not I restriction enzymatic
sites were designed for cloning the tlh gene into pGEPi vector.
The constructed pGEPi-tlh vector was transformed into E. coli
BL21 by electroporation, and a single colony from the selec-
tion plate was inoculated into 5mL LB liquid media containing
100μg/mL ampicillin for the expression of TLH antigen. The
expressed protein contains HA and Myc tags at the C-terminal
(without 6×His tag). Expression of the target protein was induced
by adding 1mM IPTG when the culture reached an OD600 of
0.8, and the induced cells were grown at 37◦C for overnight, and
then harvested by centrifugation. After SDS-PAGE, the expressed
proteins were stained using 0.3M CuCl2 by shaking for 5min at
37◦C, and visualized against a black background. The target TLH
protein bands were cut and mashed, and mixed with 1mL PBS.
The mixture solution was dialyzed with Gly/Tris buffer and the
supernatant was harvested by centrifugation, and the extracted
supernatant containing the TLH protein was visualized by SDS-
PAGE. Protein concentration was determined by the BCA protein
assay kit.
CONSTRUCTION OF EXPRESSION VECTORS FOR scFv
pET28a(+), pET32a(+), and pACYC-Duet vectors were used for
the construction of expression vectors with the scFv proteins
fused to 6×His tag, 6×His-TRX, and 6×His tag, respectively. For
co-expression, a recombinant vector pACYC-Duet-skp was first
constructed. The DNA skp gene[GeneBank:U00096.2] encoding
the molecular chaperone was amplified using the primers Skp-F
and Skp-R, and JM109 genomic DNA was used as template. The
amplified DNA fragment was digested by Bgl II and Xho I, and
ligated the pACYC-Duet vector digested with the same restriction
enzymes. To construct four different formats of expression vec-
tors, the segment encoding anti-TLH scFv was amplified using
the template vector pCANTAB-5E-scFv (Wang et al., 2012) and
the following primers (scFv-1-F and scFv-1-R for scFv-1; scFv-2-
F and scFv-2-R for scFv-2). The amplified scFv-1 fragment was
digested with EcoR I and Hind III, and ligated with pET28a(+)
and pET32a(+) vectors digested with EcoR I andHind III, and the
resultant vectors were designated as pET28a-scFv and pET32a-
scFv, respectively. The amplified scFv-2 fragment was digested
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with EcoR I and Hind III, and ligated with pACYC-Duet and
pACYC-Duet-skp vectors digested with the EcoR I and Hind III,
and the resultant vectors were designated as pACYC-Duet-scFv
and pACYC-Duet-scFv-skp, respectively.
EXPRESSION AND SOLUBLE ANALYSIS OF scFv ANTIBODIES
For protein expression, the recombinant plasmids were trans-
formed into E. coli BL21 by electroporation, and a single colony
from the selection plate was inoculated into 5mL LB liq-
uid media containing either 100μg/mL ampicillin or 50μg/mL
kanamycin or 34μg/mL chloramphenicol. The culture was incu-
bated overnight with shaking at 37◦C, and then transferred to
a larger-scale LB media (1mL culture transferred into 500mL
fresh LB). Expression of the target protein was induced by adding
1mM IPTG when the culture reached an OD600 of 0.8. Cells
were grown for an additional 12 or 32 h (only for pACYC-Duet-
scFv-skp/BL21) at 16◦C, and then harvested by centrifugation.
To ensure the accuracy of the experiment, four different derived
cultures were adjusted to the same concentration for samples
treatment, and the treated proteins were analyzed by SDS-PAGE
using 12% (v/v) polyacrylamide gels.
PURIFICATION AND IDENTIFICATION OF ANTI-TLH scFv ANTIBODIES
The purification of the expressed anti-TLH scFv was performed
using Ni2+ affinity chromatography. The expressed product was
first harvested by centrifugation (10000 r/min) at 4◦C for 10min,
followed by addition of 5mL of the binding buffer (50mM
NaH2PO4, 300mM NaCl, 1mM imidazole, 0.05% Tween 20)
after the removal of the supernatant. The complex was thenmixed
gently, sonicated and then centrifuged at 4◦C for 10min. The
supernatant was collected and loaded onto a 3mL Ni2+-NTA
column, which was equilibrated with the binding buffer before
the purification. After allowing the sample to flow-through, the
column was washed twice with the wash buffer (100mL/time),
and the wash fraction was collected for SDS-PAGE analysis. After
the wash, the retained protein of interest was eluted with 0.5mL
elution buffer 4 times, and the eluate was collected and ana-
lyzed by SDS-PAGE and verified by Western blotting. Protein
concentration was determined by the BCA protein assay kit.
ELISA ANALYSES
The activity of the purified scFv products was determined by
ELISA. The dialyzed TLH antigen (without 6×His tag) was used
to coat the 96 well plates at 4◦C for overnight. After blocking and
washing the ELISA plate, the purified scFv products derived from
four different formats of plasmids were added to the reaction
wells and incubated at 37◦C for 2 h. Then, the anti-His tag anti-
body was added to the reaction wells and incubated at 37◦C for
2 h. The binding activity of the purified scFv was detected by using
a HRP conjugated anti-mouse IgG antibody. The enzyme reaction
was then performed with TMB as a substrate and color develop-
ment was terminated with 2MH2SO4. Absorbance at 450 nmwas
measured using a microplate reader.
Similarly, ELISA was also used for the detection of bacterial
TLH. Totally, eleven different types of V. parahaemolyticus strains,
seven Vibrio strains from other species, and four non-Vibrio
bacterial strains were tested using ELISA. The bacterial cultures
were grown in 5mL APW medium without shaking at 37◦C
overnight, and then their supernatants were collected by centrifu-
gation (8000 r/min, 15min). The supernatants were added to a 96
well plate (100μL/well) to perform ELISA as described before.
WESTERN BLOTTING
To further confirm the binding activity of scFv (co-expression),
western blotting was performed as described by Singh et al. (2010)
with minor modifications. Briefly, the extracted TLH was trans-
ferred from a SDS-PAGE gel onto a polyvinylidene difluoride
(PVDF) membrane, and the membrane was treated with puri-
fied scFv antibody and anti-His tag antibody. After washing and
blocking, the membrane was subsequently incubated with HRP-
conjugated anti-mouse IgG antibody. Signals were visualized by
enhanced chemiluminescence (ECL).
ANALYSES OF ANTI-TLH scFv SPECIFICITY
ELISAwas performed to determine the specificity of the expressed
anti-TLH scFv. BSA, KLH, and associated V. parahaemolyti-
cus antigens (Vp1668 and YscF) were coated on 96-well plates
(5μg/mL, 100μL/well) at 4◦C for overnight, respectively. After
the blocking and washing, the purified scFv (pACYC-Duet-scFv-
skp) was added to the reaction wells and incubated at 37◦C
for 2 h. Then the anti-His tag antibody was added to the reac-
tion wells and incubated at 37◦C for 2 h. The specificity of the
scFv was detected with the HRP conjugated anti-mouse IgG
antibody.
AFFINITY DETERMINATION OF Skp CO-EXPRESSION scFv BY
MICROCALORIMETRY
The bio-molecular interaction and affinity of the scFv to TLHwas
measured using a TA-instrument Nano ITC-LV. The measure-
ment was automatically monitored by data acquisition software
supplied along with the instrument. All the measurements were
carried out at 25◦C. The affinity constant was calculated using
Origin software supplied with the Nano ITC-LV.
RESULTS
CONSTRUCTION OF FUSION EXPRESSION VECTORS CARRYING scFv
In this study, four different expression vectors pACYC-Duet-
scFv, pACYC-Duet-scFv-skp, pET28a-scFv, and pET32a-scFv were
constructed (Figure 1), and transformed into E. coli BL21 to
investigate their effects on solubility and activity of the expressed
scFv. Among of four expression vectors, pET28a is the basic vec-
tor for protein expression, pET32a contains a TRX tags that can
enhance the solubility of protein. While pACYC-Duet-skp con-
tains two MCS sites for different DNA insertions, and all the
expression vectors contains a 6×His tag for protein purification
and ELISA detection. To analyze the function of Skp on soluble
expression, the vector pACYC-Duet-skp was first constructed by
introducing the skp gene into the multiple cloning sites 2 with
restriction enzyme sites Bgl II and Xho I. Then the scFv gene was
cloned into the multiple cloning sites 1 via EcoR I and Hind III,
and the resulting pACYC-Duet-scFv-skp was used for the expres-
sion of both proteins (Skp and scFv) in E. coli BL21, with the
expressed scFv contains a 6×His tag at C-terminal. The expres-
sion vector pET28a-scFv encodes scFv with two 6×His tags, one
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FIGURE 1 | Constructs of scFv with different fusion formats used in this study. MCS, Multiple cloning sites; Stop, stop codon; scFv, single chain variable
fragment; Skp, molecular chaperone Skp; TRX, thioredoxin.
each at the N- and C-terminal, respectively, while the expres-
sion vector pET32a-scFv encodes a TRX-scFv fusion protein with
two 6×His tags, one each at the N-terminal and C-terminal,
respectively.
EXPRESSION AND PURIFICATION OF TLH ANTIGEN AND scFv
After the TLH protein was expressed, the total protein was ana-
lyzed by SDS-PAGE, and the gel was stained using 0.3M CuCl2,
and visualized against a black background. The target TLH pro-
tein bands were cut and mashed with PBS buffer. After harvested
by centrifugation, the extracted supernatant containing the TLH
protein was visualized by SDS-PAGE. As shown in Figure 2A,
the TLH antigen protein was expressed successfully (Figure 2A,
lane 2), and the target TLH protein was extracted with a high
purity (Figure 2A, lane 3, 4). The expressed TLH protein con-
tains HA and Myc tags (without 6×His tag), and was used as the
immobilized antigen during ELISA.
Four constructed vectors were used to transform E. coli BL21
(DE3) by electroporation for the expression of their respective
target proteins. The transformants were grown in test-tube cul-
tures and induced with 0.5mM IPTG at 16◦C for 12 or 36 h, and
the expressed products were analyzed by SDS-PAGE. As shown
in Figure 2B, the target proteins were expressed successfully in
every kind of vector, and that the apparent molecular weight of
each target scFv was consistent with its corresponding theoretical
molecular weight.
EXPRESSION AND ANALYSIS OF SOLUBILITY OF scFv
To test the solubility of expressed proteins, we lysed the cells
by ultrasonication after protein expression, and the results were
analyzed by SDS-PAGE and OD600 value. As shown in Figure 3A,
Skp co-expression (Figure 3A, lane 3) and TRX fusion expression
(Figure 3A, lane 7) were the best choices with respect to protein
solubility, in comparison to the other two fusions (Figure 3A, lane
1, 5) where a large portion proteins were expressed in an insoluble
forms (Figure 3A, lane 2, 6). This was further confirmed by the
measure of OD600 (Figure 3B). These results demonstrated that
FIGURE 2 | SDS-PAGE analysis. (A) SDS-PAGE analysis of expressed TLH
antigen protein. Lane 1: Control (empty vector pGEPi, IPTG induced); Lane
2: pGEPi-tlh expressed product (IPTG induced); Lane 3, 4: Extracted TLH
protein (without 6×His tag); (B) Expression of different scFv constructs in
E. coli BL21. M: Molecular weight of marker proteins; Lanes 1, 4, and 6:
negative control (pACYC-Duet, pET28a, and pET32a, respectively); Lane 2,
3, 5, and 7: the expressed products of pACYC-Duet-scFv,
pACYC-Duet-scFv-skp, pET28a-scFv, and pET32a-scFv, respectively.
the solubility of expressed protein was improved by either TRX
fusion or Skp co-expression.
PURIFICATION AND IDENTIFICATION OF ANTI-TLH scFv
To purify scFv protein, cells were grown for an additional 12
or 32 h with IPTG induction at 16◦C and then harvested by
centrifugation. Protein purification was performed using Ni2+
affinity chromatography, and the purified proteins were visu-
alized by SDS-PAGE using 12% (v/v) polyacrylamide gels. The
concentrations of purified proteins from four different constructs
are 0.13, 0.29, 0.115, and 0.38mg/mL, respectively. After SDS-
PAGE analysis, the target protein was further transferred onto
a PVDF membrane, and anti-6×His tag antibody was used to
confirm the presence of the expressed scFv protein. Protein purifi-
cation and western blotting results showed that all four different
fusion proteins were purified successfully (Figure 4A), and that all
four could be recognized by the anti-6×His tag antibody during
western blotting (Figure 4B).
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To compare the effects of different fusion tags on the produc-
tion of functional protein, the four purified proteins were assessed
for their binding activity to the TLH antigen by ELISA. As seen
in Figures 4C,D, amongst of four different proteins, the purified
protein derived from the pACYC-Duet-scFv-skp vector showed
the highest binding activity to TLH antigen, with the binding
activity being 3–4 folds higher than the others. Although TRX
fusion expressed scFv had higher solubility, the binding activity
of TRX fusion protein was barely satisfactory. It was lower than
that of scFv obtained by Skp co-expression, and only showed the
similar binding activity similar to the scFv expressed from the
plasmids pACYC-Duet-scFv. In fact, the scFv expressed from the
pET28a-scFv showed a very low binding activity to antigen TLH.
FIGURE 3 | Analysis of solubility of expressed products. (A) Analysis of
solubility of the expressed protein by SDS-PAGE. Lane 1, 3, 5, and 7: the
soluble cell lysates for pACYC-Duet-scFv, pACYC-Duet-scFv-skp,
pET28a-scFv, and pET32a-scFv, respectively; Lane 2, 4, 6, and 8: the
insoluble cell lysates for pACYC-Duet-scFv, pACYC-Duet-scFv-skp,
pET28a-scFv, and pET32a-scFv, respectively. (B) Cell lysates analysis by
OD600 assay (gray bar indicates the concentration of cells after protein
expression; black bar indicates the concentration of cell lysates after
ultrasonication).
SPECIFICITY ANALYSIS AND AFFINITY DETERMINATION OF scFv
OBTAINED BY Skp CO-EXPRESSION
As shown in Figure 5A, a clear band was revealed via western
blotting (Figure 5A, lane 3, 4), and the result demonstrated that
the TLH band at 47 kDa could be recognized by scFv obtained
by Skp co-expression. To further determine the specificity of Skp
co-expressed scFv protein to TLH antigen, ELISA was carried
out. As shown in Figure 5B, Skp co-expressed scFv was found
to be specific to TLH, while there was no cross binding to any
other antigen-associated proteins such as BSA, KLH, Vp1668, and
YscF. These results indicated that the co-expressed scFv could rec-
ognize TLH specifically and be used as an antibody reagent to
detect TLH.
To further probe the interaction of Skp co-expressed scFv and
TLH antigen, the affinity of anti-TLH scFv for the TLH antigen
was studied by Microcalorimetry using the Nano ITC-LV. The
measured data was used for the quantitative determination of the
affinity constant of the anti-TLH scFv antibody. It was observed
that the TLH antigen could be recognized by Skp co-expressed
scFv, and the binding activity was dose dependent. The calcu-
lated affinity constant of anti-TLH scFv was 1.254 × 108 L/mol
as determined by Origin software (Figure 5C). The above result
was consistent with our earlier results obtained by ELISA, and
the magnitude of the affinity constants consistently remain at the
level of 108 (Wang et al., 2012).
ELISA DETECTION OF TLH IN BACTERIA
We were interested in determining whether the co-expressed
scFv could serve as a good antibody reagent to directly detect
TLH from bacterial strains. In the first detection, three TLH
positive V. parahaemolyticus strains, three TLH negative Vibrio
strains and two other E. coli strains were used to identify the
FIGURE 4 | Protein purification and identification. (A) Protein
purification. The purified protein was determined by SDS-PAGE. M:
Molecular weight of marker proteins; Lane 1–4: the purified proteins for
pACYC-Duet-scFv, pACYC-Duet-scFv -skp, pET28a-scFv, and pET32a-scFv,
respectively. (B) Western blotting results. Lane 1–4: the detected bands for
pACYC-Duet-scFv, pACYC-Duet-scFv -skp, pET28a-scFv, and pET32a-scFv,
respectively. (C) ELISA. TLH antigen were coated on 96-well plates in
triplicate (5μg/mL, 100μL/well), and the purified scFv proteins were added
to the reaction wells after blocking and washing. The binding activities of
the four purified proteins were determined using an anti-6×His tag
antibody. (D) Quantitative result of ELISA∗, P < 0.05, compared with
control antibody treatment.
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FIGURE 5 | Western blotting and affinity determination. (A) Western
blotting analysis of the binding activity of scFv obtained by Skp
co-expression to the TLH antigen. Left panel: SDS-PAGE results for the
extracted TLH; Lane M: Protein molecular weight markers; Lanes 1, 2:
extracted TLH. Right panel: Western blotting results; Lanes 3, 4: TLH band
at 47 kDa bound by scFv obtained by Skp co-expression. (B) Specificity
analysis of scFv obtained by Skp co-expression. BSA, KLH, and associated
antigen proteins (VP1668 and YscF) of V. parahaemolyticus were coated on
96-well plates in triplicate (5μg/mL, 100μL/well). The purified scFv were
added to the reaction wells and incubated for 2 h at 37◦C. Specificity of
Skp co-expressed scFv was determined using an anti-6×His tag antibody.
(C) Affinity Determination of Skp co-expressed scFv. The affinity of
anti-TLH Skp co-expressed scFv for the TLH antigen was studied by
Microcalorimetry using the Nano ITC-LV. The measured data was used for
the quantitative determination of the affinity constant of the anti-TLH Skp
co-expressed scFv antibody.
practicality and feasibility of co-expressed scFv. As shown in
Figure 6, three V. parahaemolyticus strains gave the positive sig-
nal, and other five non V. parahaemolyticus strains all gave the
negative results. To further detect the accuracy of co-expressed
scFv, total 22 different bacterial strains (eleven different types
V. parahaemolyticus strains, seven Vibrio strains from other
species containing no TLH, and four other bacterial strains) were
tested. Table 2 showed that all the eleven V. parahaemolyticus
strains were successfully detected by Skp co-expressed scFv. In
contrast, seven Vibrio strains from other species and four other
bacterial strains of non-Vibrio all gave negative detection results.
These results showed that this Skp co-expressed scFv could specif-
ically recognize TLH positive V. parahaemolyticus strains, and
might be used as a potential reagent for V. parahaemolyticus
diagnosis.
DISCUSSION
Although scFv have been used as therapeutic agents and plays a
useful role in diagnosis of diseases (Saerens et al., 2008; Tong et al.,
2010), but the extensive application of scFv has been limited by
the misfolding of scFv, leading to a loss of binding activity and
the formation of inclusion bodies. To effectively solve the prob-
lem, a variety of strategies have been employed to improve the
soluble expression in different host systems. However, to date,
the bottleneck of scFv soluble expression has not been resolved,
FIGURE 6 | ELISA Detection of TLH in Bacteria. Eight different bacterial
strains (three TLH positive V. parahaemolyticus strains, three TLH negative
Vibrio strains and two other E. coli strains) were cultured in APW medium
without shaking for 16 h, and the supernatant of culture was used to coat
the 96 wells plate at 4◦C for overnight. The ELISA assay was determined
using an anti 6×His tag antibody. (PC, positive control; NC, negative
control).
and it is necessary to develop an effective method for scFv soluble
expression (Esposito and Chatterjee, 2006; Kudou et al., 2011).
Co-expression of scFv with a molecular chaperon effectively
improved the correct folding, and enhanced the solubility of scFv
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Table 2 | Detection of bacterial samples∗.
Strains TLH No. of Detection
Content tested result
TLH
Vibrio parahaemolyticus CGMCC1.2164 + 1 +
Vibrio parahaemolyticus F2002 + 1 +
Vibrio parahaemolyticus DL01 + 1 +
Vibrio parahaemolyticus CGMCC1.1997 + 1 +
Vibrio parahaemolyticus CGMCC1.1997A + 1 +
Vibrio parahaemolyticus 121 + 1 +
Vibrio parahaemolyticus 124 + 1 +
Vibrio parahaemolyticus CGMCC1.1614 + 1 +
Vibrio parahaemolyticusATCC17802 + 1 +
Vibrio parahaemolyticus CGMCC1.1615 + 1 +
Vibrio parahaemolyticus CGMCC1.1616 + 1 +
Vibrio alginolyticus CGMCC1.1833 − 2 −
Vibrio vulnificus CGMCC1.1597 − 2 −
Vibrio anguillarium CCTCCM204066 − 2 −
Vibrio harveyi CGMCC1.1601 − 1 −
Escherichia coli BL21 − 1 −
Escherichia coli DH5a − 1 −
Escherichia coli TOP10 − 1 −
Escherichia coli JM109 − 1 −
*Each strain sample had two replicates.
(Hayhurst and Harris, 1999; Sonoda et al., 2011). It is well known
that Skp is a periplasmic chaperone that can effective improve
the folding and assembly of outer membrane proteins in E. coli
(Hayhurst et al., 2003; Sonoda et al., 2011). In this study, a double
expression vector pACYC-Duet-skp was chosen for construction
of co-expression vector pACYC-Duet-scFv-skp. Two target pro-
teins were co-expressed simultaneously in a host strain, but the
expression of the two target proteins were independent, and had
different fusion protein tags. Compared to other expression for-
mats, this method neither requires removal of the fusion protein
tags, nor the need for co-transformation of plasmids, and makes
the entire process of protein purification simple, convenient, and
cost-effective. Besides, the expressed target scFv folded correctly
and retained the full binding activity with the help of molecu-
lar chaperone, and the purified protein could be used directly
for different purposes without refolding of protein in vitro after
purification.
In this study, four different format expression vectors
were constructed for soluble expression of scFv. Amongst the
four purified protein, the Skp co-expressed scFv showed a
higher solubility, and a 3–4 fold higher binding to antigen
TLH than the other three purified proteins. Besides, the Skp
co-expressed scFv was specific for TLH and did not cross-
react with other TLH-associated proteins. Although TRX fusion
expressed scFv had higher solubility, but the binding activ-
ity of TRX fusion protein was lower than Skp co-expressed
scFv (Marblestone et al., 2006; Subedi et al., 2012). Together,
the results demonstrate that the pACYC-Duet-Skp vector sys-
tem is an effective expression system for soluble expression
of scFv.
Low temperature is an important factor in soluble protein
expression (Qing et al., 2004; Sørensen and Mortensen, 2011).
To effectively express the soluble scFv, different temperatures
(such as 37, 30, 25, and 16◦C) were used. The result demon-
strated that the soluble expression of scFv was improved greatly
at low temperature (16◦C), the expressed scFv had the highest
solubility and binding activity (data not shown). This improve-
ment of solubility can be attributed to the following three
advantages of lower expression temperature: (1) The expres-
sion rate of protein is greatly reduced, leading to enhanced
the folding efficiency of protein; (2) The endogenous pro-
teases are usually inactive or have low-activity, leading to an
enhancement of target protein stability (Subedi et al., 2012);
(3) The metabolic pressure of host cells is decreased owing to
the reduced the cytotoxicity of the expressed protein. However,
the true mechanism of efficient expression at low tempera-
ture is still unclear, and additional works would be needed to
understand this.
CONCLUSIONS
We constructed four different expression vectors, and tested their
ability to express the soluble scFv protein. The solubility and
binding activity of the purified protein were analyzed by SDS-
PAGE and ELISA, respectively. Amongst the four purified protein,
the Skp co-expressed scFv showed the highest solubility, and the
binding activity to antigen TLH was 3–4 fold higher than other
three purified scFv. Also, the scFv obtained by Skp co-expression
was specific for TLH and did not cross-react with other TLH-
associated proteins. Notably, this scFv could be used to detect
TLH directly in real samples, suggesting that the pACYC-Duet-
skp vector system is an effective system for soluble expression
of scFv.
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